Weisel, Katja C.
Scheid, Christof
Zago, Manola
Besemer, Britta
Mai, Elias K. http://orcid.org/0000-0002-6226-1252
Haenel, Mathias
Duerig, Jan
Munder, Markus
Lindemann, Hans-Walter
Seckinger, Anja
Kunz, Christina
Benner, Axel http://orcid.org/0000-0002-7238-6956
Hose, Dirk
Jauch, Anna
Salwender, Hans
Goldschmidt, Hartmut
Article History
Received: 23 January 2019
Revised: 18 March 2019
Accepted: 21 March 2019
First Online: 8 April 2019
Conflict of interest
: K.W. reports research funding from Janssen, Amgen, Sanofi, and Celgene Corporation; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Janssen, Novartis, Onyx, and Takeda; and advisory board membership for Adaptive Biotech, Amgen, Bristol-Myers Squibb, Celgene Corporation, Janssen, Novartis, Onyx, and Takeda. C.S. reports honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Janssen, Novartis, Sanofi, Takeda, and advisory board membership for Amgen, Bristol-Myers Squibb, Celgene Corporation, Janssen, Novartis, Sanofi, and Takeda. E.K.M. reports personal fees and other from Janssen Cilag, personal fees and other from Celgene, personal fees and other from Takeda, other from Bristol-Myers Squibb, and other from Mundipharma; M.H. reports honoraria from Novartis and Roche. J.D. reports research funding from Lead Discovery Center. M.M. reports personal fees from Celgene, personal fees and other from Janssen, grants and personal fees from Bristol-Myers Squibb, personal fees and other from Takeda, and personal fees and other from Amgen. H.S. reports research funding from Amgen, Novartis, Janssen, Bristol-Myers Squibb, and Celgene Corporation, honoraria from Novartis, Janssen, Bristol-Myers Squibb, Celgene Corporation, and Takeda, and travel support from Amgen, Celgene Corporation, and Janssen. H.G. reports personal fees and other from Amgen, personal fees and other from Bristol-Myers Squibb, personal fees and other from Celgene, personal fees and other from Chugai, personal fees and other from Janssen, personal fees and other from Sanofi, other from Mundipharma, personal fees and other from Takeda, personal fees and other from Novartis, other from Adaptive Biotechnologies, personal fees from Art Tempi, outside the submitted work. The remaining authors declare that they have no conflict of interest.